日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lymphocyte subset reconstitution and clinical outcomes following haploidentical hematopoietic stem cell transplantation

单倍体造血干细胞移植后淋巴细胞亚群重建及临床结果

Jiang, Peiyao; Zhou, Xiao; Cai, Yu; Yang, Jun; Zhou, Kun; Tong, Yin; Huang, Chongmei; Dong, Baoxia; Qiu, Huiying; Xu, Xiaowei; Niu, Jiahua; Shen, Chang; Xia, Xinxin; Zhang, Ying; Song, Xianmin; Wan, Liping

Quantitative evaluation of T-cell repertoire restoration following hematopoietic stem cell transplantation in patients with and without graft versus host disease

对接受造血干细胞移植且伴有和不伴有移植物抗宿主病的患者进行造血干细胞移植后T细胞库恢复的定量评估

Zhang, Xin; Song, Pengyi; Tang, Longhai; Ji, Xiangjun; Hu, Xiaohui; Ma, Xiao; Chen, Feng; He, Xuefeng; Wang, Jun; Li, Weiyang; Qiu, Huiying; Xue, Shengli; Wang, Ying; Miao, Miao; Chen, Suning; Wu, Depei; Tang, Xiaowen; Wang, Mingyuan; Wang, Wenbo; Tian, Xiaopeng

Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab

CAR-T细胞疗法治疗既往接受过blinatumomab治疗的B-ALL患者的疗效和安全性

Chu, Yurou; Zhou, Biqi; Gao, Rui; Miao, Miao; Qiu, Huiying; Tang, Xiaowen; Wang, Ying; Chen, Suning; Kang, Liqing; Wu, Depei; Xu, Yang

Venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed CBFβ::MYH11(+) acute myeloid leukemia

维奈托克联合去甲基化药物治疗新诊断和复发性 CBFβ::MYH11(+) 急性髓系白血病

Feng, Ziyu; Hu, Xiaohui; Li, Weiyang; Xu, Ting; Xu, Yang; Xue, Shengli; Qiu, Huiying; Tang, Xiaowen; Han, Yue; Chen, Suning; Sun, Aining; Zhang, Yanming; Wu, Depei; Wang, Ying

Haploidentical donor vs. human leukocyte antigen-matched donor hematopoietic cell transplantation for elderly patients with hematologic malignancies: Inferior non-relapse mortality but comparable survival

对于老年血液系统恶性肿瘤患者,单倍体相合供者与人类白细胞抗原(HLA)匹配供者的造血干细胞移植:非复发死亡率较低,但生存率相当。

Xiang, Mengqi; Zhang, Xiang; Xu, Mimi; Tu, Yuqing; Shen, Juan; Li, Xiaoli; Wu, Xiaojin; Chen, Suning; Wang, Ying; Han, Yue; Miao, Miao; Sun, Aining; Qiu, Huiying; Fan, Yi; Wu, Depei; Chen, Jia

A molecular-based risk score for predicting leukemia-free survival in adult AML patients undergoing Allo-HSCT

一种基于分子水平的风险评分,用于预测接受异基因造血干细胞移植的成人急性髓系白血病患者的无白血病生存期。

Li, Shuang; Wu, Huixian; Hu, Xiaoxia; Zhou, Fang; Ni, Xiong; Ding, Yi; Wan, Jiangbo; Wang, Xiaorui; Cai, Yu; Yang, Jun; Tong, Yin; Qiu, Huiying; Huang, Chongmei; Zhou, Kun; Wan, Liping; Song, Xianmin

DEK facilitates bortezomib resistance of multiple myeloma by modulating ferroptosis.

DEK 通过调节铁死亡促进多发性骨髓瘤对硼替佐米产生耐药性

Wang Huiquan, Zhang Jiafeng, Chen Lei, Ren Hefei, Liu Chang, Wu Hong Kun, Qiu Huiying, Lu Juan, Zhou Lin

Age- and comorbidity-adjusted busulfan, fludarabine, cytarabine, and low-dose TBI-based conditioning regimen is effective for myelodysplastic syndromes with excess blasts undergoing allogeneic peripheral blood stem cell transplantation

对于伴有原始细胞过多的骨髓增生异常综合征患者,采用基于白消安、氟达拉滨、阿糖胞苷和低剂量全身照射的预处理方案,并根据年龄和合并症进行调整,可有效进行异基因外周血干细胞移植。

Gao, Jie; Wu, Huixian; Qiu, Huiying; Tong, Yin; Huang, Chongmei; Yang, Jun; Dong, Baoxia; Niu, Jiahua; Zhou, Kun; Cai, Yu; Shen, Chang; Xia, Xinxin; Song, Xianmin; Wan, Liping

Epstein-Barr virus reactivation after haplo-peripheral blood stem cell transplantation in patients with hematological malignancies: immune reconstitution and influence on survival

血液系统恶性肿瘤患者接受单倍体外周血干细胞移植后EB病毒再激活:免疫重建及其对生存的影响

Ma, Ling; Zhang, Ying; Wang, Ting; Cai, Yu; Yang, Jun; Tong, Yin; Huang, Chongmei; Qiu, Huiying; Zhou, Kun; Xu, Xiaowei; Niu, Jiahua; Shen, Chang; Xia, Xinxin; Wei, Yu; Shao, Jie; Yang, Min; Cao, Jingjing; Song, Xianmin; Wan, Liping

IPSS-M outperforms IPSS-R in prognostic stratification and guides effective interventions for very High-Risk myelodysplastic syndrome patients undergoing allogeneic hematopoietic stem cell transplantation

IPSS-M 在预后分层方面优于 IPSS-R,并能指导对接受异基因造血干细胞移植的极高危骨髓增生异常综合征患者进行有效干预。

Wu, Huixian; Li, Shuang; Yang, Jun; Cai, Yu; Qiu, Huiying; Huang, Chongmei; Tong, Yin; Zhou, Kun; Niu, Jiahua; Xia, Xinxin; Zhang, Ying; Xu, Xiaowei; Shen, Chang; Dong, Baoxia; Wan, Liping; Song, Xianmin